 | • レポートコード：D005-00174 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、セリアック病治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。セリアック病治療薬の種類別市場規模（一次治療、二次治療）、用途別市場規模（病院、研究）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Novartis、BiolineRx、Merck、ImmusanT、Johnson & Johnson、Immunomedics、Innovate Biopharmaceuticals、Pfizer、Bristol-Myers Squibb ・地域別グローバル市場分析 2015年-2020年 ・セリアック病治療薬の北米市場（アメリカ、カナダ、メキシコ） ・セリアック病治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・セリアック病治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・セリアック病治療薬の南米市場（ブラジル、アルゼンチン） ・セリアック病治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：一次治療、二次治療 ・用途別分析：病院、研究 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Celiac Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Celiac Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Celiac Disease Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Celiac Disease Drugs market has been segmented into:
First Line of Treatment
Second Line of Treatment
By Application, Celiac Disease Drugs has been segmented into:
Hospital
Research
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Celiac Disease Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Celiac Disease Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Celiac Disease Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Celiac Disease Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Celiac Disease Drugs Market Share Analysis
Celiac Disease Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Celiac Disease Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Celiac Disease Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Celiac Disease Drugs are:
Roche
Novartis
BiolineRx
Merck
ImmusanT
Johnson & Johnson
Immunomedics
Innovate Biopharmaceuticals
Pfizer
Bristol-Myers Squibb
Table of Contents
1 Celiac Disease Drugs Market Overview
1.1 Product Overview and Scope of Celiac Disease Drugs
1.2 Classification of Celiac Disease Drugs by Type
1.2.1 Global Celiac Disease Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Celiac Disease Drugs Revenue Market Share by Type in 2019
1.2.3 First Line of Treatment
1.2.4 Second Line of Treatment
1.3 Global Celiac Disease Drugs Market by Application
1.3.1 Overview: Global Celiac Disease Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Research
1.4 Global Celiac Disease Drugs Market by Regions
1.4.1 Global Celiac Disease Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Celiac Disease Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Celiac Disease Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Celiac Disease Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Celiac Disease Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Celiac Disease Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Celiac Disease Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Celiac Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Celiac Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 BiolineRx
2.3.1 BiolineRx Details
2.3.2 BiolineRx Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BiolineRx SWOT Analysis
2.3.4 BiolineRx Product and Services
2.3.5 BiolineRx Celiac Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Celiac Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 ImmusanT
2.5.1 ImmusanT Details
2.5.2 ImmusanT Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 ImmusanT SWOT Analysis
2.5.4 ImmusanT Product and Services
2.5.5 ImmusanT Celiac Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Celiac Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Immunomedics
2.7.1 Immunomedics Details
2.7.2 Immunomedics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Immunomedics SWOT Analysis
2.7.4 Immunomedics Product and Services
2.7.5 Immunomedics Celiac Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Innovate Biopharmaceuticals
2.8.1 Innovate Biopharmaceuticals Details
2.8.2 Innovate Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Innovate Biopharmaceuticals SWOT Analysis
2.8.4 Innovate Biopharmaceuticals Product and Services
2.8.5 Innovate Biopharmaceuticals Celiac Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Celiac Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bristol-Myers Squibb SWOT Analysis
2.10.4 Bristol-Myers Squibb Product and Services
2.10.5 Bristol-Myers Squibb Celiac Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Celiac Disease Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Celiac Disease Drugs Players Market Share
3.2.2 Top 10 Celiac Disease Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Celiac Disease Drugs Revenue and Market Share by Regions
4.2 North America Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
5 North America Celiac Disease Drugs Revenue by Countries
5.1 North America Celiac Disease Drugs Revenue by Countries (2015-2020)
5.2 USA Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
6 Europe Celiac Disease Drugs Revenue by Countries
6.1 Europe Celiac Disease Drugs Revenue by Countries (2015-2020)
6.2 Germany Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
6.4 France Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Celiac Disease Drugs Revenue by Countries
7.1 Asia-Pacific Celiac Disease Drugs Revenue by Countries (2015-2020)
7.2 China Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
7.5 India Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
8 South America Celiac Disease Drugs Revenue by Countries
8.1 South America Celiac Disease Drugs Revenue by Countries (2015-2020)
8.2 Brazil Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Celiac Disease Drugs by Countries
9.1 Middle East & Africa Celiac Disease Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Celiac Disease Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Celiac Disease Drugs Market Forecast by Type (2019-2024)
10.3 First Line of Treatment Revenue Growth Rate (2015-2025)
10.4 Second Line of Treatment Revenue Growth Rate (2015-2025)
11 Global Celiac Disease Drugs Market Segment by Application
11.1 Global Celiac Disease Drugs Revenue Market Share by Application (2015-2020)
11.2 Celiac Disease Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Research Revenue Growth (2015-2020)
12 Global Celiac Disease Drugs Market Size Forecast (2021-2025)
12.1 Global Celiac Disease Drugs Market Size Forecast (2021-2025)
12.2 Global Celiac Disease Drugs Market Forecast by Regions (2021-2025)
12.3 North America Celiac Disease Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Celiac Disease Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Celiac Disease Drugs Revenue Market Forecast (2021-2025)
12.6 South America Celiac Disease Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Celiac Disease Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Celiac Disease Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Celiac Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Celiac Disease Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Celiac Disease Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Corporate Information, Location and Competitors
Table 6. Roche Celiac Disease Drugs Major Business
Table 7. Roche Celiac Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Roche SWOT Analysis
Table 9. Roche Celiac Disease Drugs Product and Solutions
Table 10. Roche Celiac Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Novartis Corporate Information, Location and Competitors
Table 12. Novartis Celiac Disease Drugs Major Business
Table 13. Novartis Celiac Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Novartis SWOT Analysis
Table 15. Novartis Celiac Disease Drugs Product and Solutions
Table 16. Novartis Celiac Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. BiolineRx Corporate Information, Location and Competitors
Table 18. BiolineRx Celiac Disease Drugs Major Business
Table 19. BiolineRx Celiac Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 20. BiolineRx SWOT Analysis
Table 21. BiolineRx Celiac Disease Drugs Product and Solutions
Table 22. BiolineRx Celiac Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck Corporate Information, Location and Competitors
Table 24. Merck Celiac Disease Drugs Major Business
Table 25. Merck Celiac Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Merck SWOT Analysis
Table 27. Merck Celiac Disease Drugs Product and Solutions
Table 28. Merck Celiac Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. ImmusanT Corporate Information, Location and Competitors
Table 30. ImmusanT Celiac Disease Drugs Major Business
Table 31. ImmusanT Celiac Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 32. ImmusanT SWOT Analysis
Table 33. ImmusanT Celiac Disease Drugs Product and Solutions
Table 34. ImmusanT Celiac Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Johnson & Johnson Corporate Information, Location and Competitors
Table 36. Johnson & Johnson Celiac Disease Drugs Major Business
Table 37. Johnson & Johnson Celiac Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Johnson & Johnson SWOT Analysis
Table 39. Johnson & Johnson Celiac Disease Drugs Product and Solutions
Table 40. Johnson & Johnson Celiac Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Immunomedics Corporate Information, Location and Competitors
Table 42. Immunomedics Celiac Disease Drugs Major Business
Table 43. Immunomedics Celiac Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Immunomedics SWOT Analysis
Table 45. Immunomedics Celiac Disease Drugs Product and Solutions
Table 46. Immunomedics Celiac Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Innovate Biopharmaceuticals Corporate Information, Location and Competitors
Table 48. Innovate Biopharmaceuticals Celiac Disease Drugs Major Business
Table 49. Innovate Biopharmaceuticals Celiac Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Innovate Biopharmaceuticals SWOT Analysis
Table 51. Innovate Biopharmaceuticals Celiac Disease Drugs Product and Solutions
Table 52. Innovate Biopharmaceuticals Celiac Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Pfizer Corporate Information, Location and Competitors
Table 54. Pfizer Celiac Disease Drugs Major Business
Table 55. Pfizer Celiac Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Pfizer SWOT Analysis
Table 57. Pfizer Celiac Disease Drugs Product and Solutions
Table 58. Pfizer Celiac Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 60. Bristol-Myers Squibb Celiac Disease Drugs Major Business
Table 61. Bristol-Myers Squibb Celiac Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 62. Bristol-Myers Squibb SWOT Analysis
Table 63. Bristol-Myers Squibb Celiac Disease Drugs Product and Solutions
Table 64. Bristol-Myers Squibb Celiac Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Celiac Disease Drugs Revenue (Million USD) by Players (2015-2020)
Table 66. Global Celiac Disease Drugs Revenue Share by Players (2015-2020)
Table 67. Global Celiac Disease Drugs Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Celiac Disease Drugs Revenue Market Share by Regions (2015-2020)
Table 69. North America Celiac Disease Drugs Revenue by Countries (2015-2020)
Table 70. North America Celiac Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 71. Europe Celiac Disease Drugs Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Celiac Disease Drugs Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Celiac Disease Drugs Revenue by Countries (2015-2020)
Table 74. South America Celiac Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Celiac Disease Drugs Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Celiac Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Global Celiac Disease Drugs Revenue (Million USD) by Type (2015-2020)
Table 78. Global Celiac Disease Drugs Revenue Share by Type (2015-2020)
Table 79. Global Celiac Disease Drugs Revenue Forecast by Type (2021-2025)
Table 80. Global Celiac Disease Drugs Revenue by Application (2015-2020)
Table 81. Global Celiac Disease Drugs Revenue Share by Application (2015-2020)
Table 82. Global Celiac Disease Drugs Revenue Forecast by Application (2021-2025)
Table 83. Global Celiac Disease Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Celiac Disease Drugs Picture
Figure 2. Global Celiac Disease Drugs Revenue Market Share by Type in 2019
Figure 3. First Line of Treatment Picture
Figure 4. Second Line of Treatment Picture
Figure 5. Celiac Disease Drugs Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Research Picture
Figure 8. Global Celiac Disease Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Celiac Disease Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Celiac Disease Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Celiac Disease Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Celiac Disease Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Celiac Disease Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Celiac Disease Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Celiac Disease Drugs Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Celiac Disease Drugs Revenue Market Share in 2019
Figure 17. Global Top 10 Players Celiac Disease Drugs Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Celiac Disease Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Celiac Disease Drugs Revenue Market Share by Regions (2015-2020)
Figure 21. Global Celiac Disease Drugs Revenue Market Share by Regions in 2018
Figure 22. North America Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 23. Europe Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 25. South America Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 27. North America Celiac Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 28. North America Celiac Disease Drugs Revenue Market Share by Countries in 2019
Figure 29. USA Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 30. Canada Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Europe Celiac Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Celiac Disease Drugs Revenue Market Share by Countries in 2019
Figure 34. Germany Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 35. UK Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 36. France Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 37. Russia Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 38. Italy Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Celiac Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Celiac Disease Drugs Revenue Market Share by Countries in 2019
Figure 41. China Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Japan Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Korea Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 44. India Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 46. South America Celiac Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 47. South America Celiac Disease Drugs Revenue Market Share by Countries in 2019
Figure 48. Brazil Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Celiac Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Celiac Disease Drugs Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 53. UAE Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Celiac Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 56. Global Celiac Disease Drugs Revenue Share by Type (2015-2020)
Figure 57. Global Celiac Disease Drugs Revenue Share by Type in 2019
Figure 58. Global Celiac Disease Drugs Market Share Forecast by Type (2021-2025)
Figure 59. Global First Line of Treatment Revenue Growth Rate (2015-2020)
Figure 60. Global Second Line of Treatment Revenue Growth Rate (2015-2020)
Figure 61. Global Celiac Disease Drugs Revenue Share by Application (2015-2020)
Figure 62. Global Celiac Disease Drugs Revenue Share by Application in 2019
Figure 63. Global Celiac Disease Drugs Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospital Revenue Growth Rate (2015-2020)
Figure 65. Global Research Revenue Growth Rate (2015-2020)
Figure 66. Global Celiac Disease Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Celiac Disease Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Celiac Disease Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Celiac Disease Drugs Revenue Market Forecast (2021-2025)
Figure 70. Europe Celiac Disease Drugs Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Celiac Disease Drugs Revenue Market Forecast (2021-2025)
Figure 72. South America Celiac Disease Drugs Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Celiac Disease Drugs Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
メニエール病薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Meniere's Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meniere's Disease Dru…- 炎症性腸疾患治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Inflammatory Bowel Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Inflammatory…
- クラッベ病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Krabbe Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Krabbe Disease Treat…
- パーキンソン病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Parkinson's Disease Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Parkinson's Di…
- シャーガス病治療の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chagas Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 253.5 million by 2025, from USD 223.8 million in 2019. The Chagas Diseas…